doi:10.1001/jama.2026.0035 3
Asandra about any and all health-related concerns during your consultation
To view or add a comment, sign in More Relevant Posts GLP-1 Analogues: The Hottest Trend in Pharma Right Now Download PDF Brochure @ GLP-1 Analogues have become an important therapeutic class for managing type 2 diabetes and obesity through mechanisms that enhance insulin secretion, suppress glucagon release, delay gastric emptying, and promote satiety
Instead, CMS is extending the duration of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
1) Nutrition and labs, first
The GLP-1 receptor agonist drug class became a household name almost overnight thanks to the success of Novo Nordisk's semaglutide, marketed as Wegovy for weight loss and more recently as Ozempic for type 2 diabetes